About this trial
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend pancreatic stent in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula and to investigate its long term clinical outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing pancreaticoduodenectomy (Whipple procedure) for various indications (e.g., pancreatic cancer, ampullary cancer, etc.).
Patients with a confirmed soft pancreas texture, as determined intraoperatively by the surgeon.
Disqualifiers
Patients with a hard or fibrotic pancreas, as determined intraoperatively by the surgeon.
Patients with severe uncontrolled comorbidities (e.g., uncontrolled diabetes, severe cardiovascular disease, renal failure).
Pregnancy or lactation.
Trial design
Parallel
Treatments tested in this trial
Pancreaticojejunostomy with external stent
Procedure/SurgeryInserting ureteric stent at the pancreaticojejunostomy site
Pancreaticojejunostomy without external stent
Procedure/SurgeryOnly Pancreaticojejunostomy without inserting external stent
Treatment groups
Trial outcomes
Primary outcomes
evidence of pancreatic fistula
confirmed by serum and drain amylase
Secondary outcomes
evidence of intra abdominal collection
confirmed by abdominal ultrasound and abdominal computed tomography
Sponsors and contacts
Click on the lead sponsor to view all of their trials.